Average Co-Inventor Count = 3.85
ph-index = 6
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Allergan, Inc. (15 from 2,285 patents)
15 patents:
1. 9540332 - Benzimidazole derivatives as selective blockers of persistent sodium current
2. 8859780 - Benzimidazole derivatives as selective blockers of persistent sodium current
3. 8153645 - Treating pain using selective antagonists of persistent sodium current
4. 8124612 - Treating neurological disorders using selective antagonists of persistent sodium current
5. 7767718 - Treating pain using selective antagonists of persistent sodium current
6. 7763651 - Treating pain using selective antagonists of persistent sodium current
7. 7754440 - High-throughput screen for identifying selective persistent sodium channels channel blockers
8. 7728034 - Treating neurological disorders using selective antagonists of persistent sodium current
9. 7723053 - High-throughput screen for identifying selective persistent sodium channels channel blockers
10. 7705055 - Treating neurological disorders using selective antagonists of persistent sodium current
11. 7361478 - High-throughput screen for identifying selective persistent sodium channels channel blockers
12. 7125908 - Treating pain using selective antagonists of persistent sodium current
13. 7060723 - Treating neurological disorders using selective antagonists of persistent sodium current
14. 6991910 - High-throughput screen for identifying channel blockers that selectively distinguish transient from persistent sodium channels
15. 6479458 - Targeting the reverse mode of the Na+/Ca2+ exchanger for the treatment of optic neuropathy associated with glaucoma and ischemic optic neuropathy